Focus
Focus, licence 80088282: inactive licence in Health Canada data. The French and European references below do not constitute authorisation for sale in France or an assessment of safety or efficacy.
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
Natural health product licensed in Canada
- Licence holder
- ATP ATHLÉTIQUE ET THÉRAPEUTIQUE PHARMA INC. ou ATP ATHLETIC AND THERAPEUTIC PHARMA INC.
- NPN or DIN-HM
- 80088282
- Status
- Inactive licence
- Licence date
- 7 September 2018
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| L-Tyrosine Source : N-acétyltyrosine | 62.5 mg | Not calculated |
| Phosphatidylsérine Source : Lécithine de soja enrichie en phosphatidylsérine | 100.0 mg | Not calculated |
| Bacopa monnieri Source : Sommité Extract : Matériel brut sec Extraction ratio : 2:1 Dry plant equivalent : 150 mg Potency : 55.0 % Bacosides | 75.0 mg | Not calculated |
| Sel interne de (2R)-2-(Acétyloxy)-3-carboxy-N,N,N-triméthyl-1-propanaminium Source : Acétyl-L-Carnitine | 125.0 mg | Not calculated |
| L-alpha-Glycérophosphorylcholine Source : Alfoscérate de choline | 37.5 mg | Not calculated |
| Cytidine 5'-diphosphocholine Source : Citicoline | 37.5 mg | Not calculated |
Non-medicinal ingredients
Hydroxypropylméthylcellulose
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | minimum: 19.0 Année(s) | 1.0 Capsule | 2.0 Tous les jours |
Uses authorised in Canada
Used in Herbal Medicine) (as an adaptogen) (to) help(s) (to) temporary relieve symptoms of stress (such as mental fatigue and sensation of weakness). (Used in Herbal Medicine) (to) help(s) support cognitive function (such as mental focus and mental stamina).
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Effets indésirables connus
If you experience irritability or insomnia, discontinue use. May cause digestive problems.
- Contre-indications
If you have bipolar disorder or bipolar spectrum disorder, do not use this product.
- Précautions et mises en garde
If symptoms persist or worsen, consult a health care practitioner. If you are pregnant or breastfeeding, consult a health care practitioner prior to use. If you are taking antidepressant medication, consult a health care practitioner prior to use. If you are taking hormone replacement therapy (HRT) or birth control pills, consult a health care practitioner prior to use. Consult a health care practitioner prior to use if you are following a low protein diet. If you have liver disease, kidney disease and/or a seizure disorder, consult a health care practitioner prior to use.
Source
Official Health Canada record, licence 80088282
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.